Immunohistochemistry results of the Qilu cohort also revealed that tumours with higher risk scores were more likely to have higher Ki-67 positive rates (Fisher’s exact test, p = 0.08938), further confirming that the risk score was associated with proliferative activity. This evidence concerns the gene MKI67 and neoplasm.